None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients who have undergone total mastectomy or partial mastectomy for breast cancer. 2. Patients presenting with a palpable taut band and a tender point upon examination. 3. Patients who report pain reproduction upon compression of the tender point. 4. Patients diagnosed with myofascial pain syndrome by a clinician. Participants were identified through electronic medical records (EMR) as patients diagnosed by a clinician. In cases where a formal diagnosis was not explicitly documented, individuals exhibiting clinical features consistent with myofascial pain syndrome were included based on assessment by a physical therapist with clinical experience.
Exclusion criteria
Exclusion criteria: 1. Patients with skin infection or inflammation. 2. Patients with contraindications to Myofascial Release (MFR) or Muscle Energy Technique (MET). 3. Patients who have difficulty maintaining the required position due to the presence of a chemoport or other medical devices. 4. Patients with lymphedema of stage II or higher. - Adverse Event Monitoring 1. Upper limb circumference will be measured using a tape measure before and after each intervention session. 2. Participants may be withdrawn from the study if edema persistently increases or worsens during the intervention period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain Pressure Threshold | — |
Secondary
| Measure | Time frame |
|---|---|
| Shoulder Pain and Disability Index;European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 | — |
Countries
Korea, Republic of
Contacts
Gachon University